Clinical Research of Retrograde Infraclavicular Brachial Plexus Blockade
NCT ID: NCT01075503
Last Updated: 2010-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2008-03-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block
NCT01605929
Selective Trunk Brachial Plexus Block
NCT04510259
Comparison of Costoclavicular and Paracoracoid Approaches to Infraclavicular Brachial Plexus Blocks
NCT05260736
Prospective Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus Block
NCT02208245
Selective Trunk Block: A Study to Evaluate Block Dynamics, Effects and Efficacy for Upper Limb Surgery
NCT04752410
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
retrograde infraclavicular
Patients were received retrograde infraclavicular brachial plexus block.
brachial plexus block
0.5% Ropivacaine 40ml
interscalene
Patients were received interscalene brachial plexus block.
brachial plexus block
0.5% Ropivacaine 40ml
supraclavicular
Patients were received supraclavicular brachial plexus block.
brachial plexus block
0.5% Ropivacaine 40ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
brachial plexus block
0.5% Ropivacaine 40ml
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective upper extremity surgery
Exclusion Criteria
* Body weight \<50kg or \>100kg
* Serious brain, heart, lung, liver, kidney diseases or diabetes mellitus
* Incapability or refusing to be enrolled
* Infection at the site of puncture, skin ulcer
* Coagulopathy
* Contralateral phrenic nerve paralysis, contralateral recurrent laryngeal nerve paralysis or pneumothorax
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Jishuitan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beijing jishuitan hospital, China
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaoguang Zhang, MB
Role: PRINCIPAL_INVESTIGATOR
Department of anesthesiology, Beijing jishuitan hospital, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing jishuitan hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JSTMZ.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.